# A Study Evaluating Drug Drug Interaction Between Milvexian and Atorvastatin in Healthy Participants

> **NCT04388501** · PHASE1 · COMPLETED · sponsor: **Janssen Pharmaceutica N.V., Belgium** · enrollment: 23 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Milvexian
- **DRUG:** Atorvastatin

## Key facts

- **NCT ID:** NCT04388501
- **Lead sponsor:** Janssen Pharmaceutica N.V., Belgium
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-07
- **Primary completion:** 2021-10-25
- **Final completion:** 2021-10-27
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2025-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04388501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04388501, "A Study Evaluating Drug Drug Interaction Between Milvexian and Atorvastatin in Healthy Participants". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04388501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*